WHO 2016 polycythemia vera criteria (Arber 2016). Met when all three majors hold, or when major 1 and major 2 hold with subnormal EPO. Major 1 is male Hb >16.5 g/dL or Hct >49%, female Hb >16.0 or Hct >48%, or increased red-cell mass. Major 2 is caller-assigned marrow panmyelosis. Major 3 is JAK2 V617F or exon 12. Not a medical device, not a WHO diagnosis, and not WHO 2022. magent does not assay EPO or sequence JAK2.

Jacobs 2022 Table 3 Cox linear predictor for overall survival after resected major salivary gland cancer with versus without postoperative radiotherapy. Age per 10 years by PORT, male, Charlson-Deyo per point, gland, PORT by T stage, nodal-positivity ratio band, grade step, and positive margin as ln(HR). Not a 2-/5-/10-year OS percent (no printed S0). Not a radiation order. magent does not compute Charlson-Deyo or count nodes.

Iba 2017 SIC (Table 3; max 6). platelets_10e9_l >=150=0, <150 and >=100=1, <100=2. inr <=1.2=0, >1.2 and <=1.4=1, >1.4=2. sofa_four_items is the caller-assigned respiratory+cardiovascular+hepatic+renal SOFA sum (0-16; not coagulation, not CNS): 0=0, 1=1, >=2=2 (cap 2). sic true iff score >=4 and platelet_pts+inr_pts >=3. Not a sepsis or DIC diagnosis. Not ISTH overt DIC. Not JAAM-DIC. magent does not start anticoagulants.

Corrected reticulocyte count (retic% × Hct/45), Hillman 1969 maturation-shift reticulocyte index, and optional absolute reticulocyte count. Deterministic published arithmetic with citation; not a marrow diagnosis.

Sokal 1984 relative-risk index for newly diagnosed untreated chronic granulocytic leukemia (CML). sokal_index = exp(0.0116*(age-43.4)+0.0345*(spleen_cm-7.51)+0.188*((platelets_10e9_l/700)^2-0.563)+0.0887*(blasts_percent-2.10)). Low <0.8, intermediate 0.8–1.2, high >1.2. Coefficient 0.188. Does not diagnose CML or choose TKI therapy.

Hoddes 1973 Stanford Sleepiness Scale degree 1-7 as assigned by the caller. Returns the degree, score (same as the degree), max 7, and published wording (feeling active and vital; alert; wide awake through almost in reverie; sleep onset soon). Not the Epworth Sleepiness Scale. Not a sleep-disorder diagnosis; magent does not observe the patient.

THRIVE (Totaled Health Risks in Vascular Events; Flint 2010 AJNR) from trichotomized age (<=59 0, 60-79 1, >=80 2), trichotomized NIHSS (<=10 0, 11-20 2, >=21 4), and chronic disease scale (hypertension, diabetes, atrial fibrillation; 1 each). Score 0-9; bands low 0-2, moderate 3-5, high 6-9 with published 90-day mRS 0-2 and mortality percents. Not a treatment recommendation. magent does not examine the patient or assign NIHSS.

Heide 2001 SCORMA: extent_percent/5 + 5*intensity_sum + 2*symptom_sum/5. Extent 0-100 (diffuse cutaneous mastocytosis is 100). Four intensity signs 0-3 (pigmentation, vesiculation, elevation/induration, Darier's sign). Five symptoms 0-10 (flushing, provocation factors, diarrhoea, bone pain, pruritus). Max 100. magent does not examine the skin. Not a diagnosis, WHO/ICC criteria, REMA, or tryptase.

Lakshman 2018 2/20/20 smoldering myeloma risk: one point each for BMPC >20%, serum M-protein >2 g/dL, and involved/uninvolved FLC ratio >20 (strict greater-than). 0 factors low (median TTP 110 months), 1 intermediate (68), 2 or 3 high (29). Not Mayo 70/20, not PETHEMA, not myeloma ISS, not a treatment order. BMPC 10-59 and FLC 0.01-99.9 (IMWG 2014 SLiM myeloma is rejected). magent does not assay marrow, M-protein, or free light chains.

ROPE (Risk of Paradoxical Embolism; Kent 2013 Neurology Table 4) from age decades (18-29 5, 30-39 4, 40-49 3, 50-59 2, 60-69 1, >=70 0) plus five caller-assigned 1-point factors (no hypertension, no diabetes, no prior stroke/TIA, nonsmoker, cortical infarct). Score 0-10 with abstract groupings 0-3, 4-8 residual, and 9-10. Not a PFO diagnosis, not a closure indication, not PASCAL. magent does not read imaging or a smoking history.

Aletaha 2005 Simplified Disease Activity Index (SDAI): sjc28 + tjc28 + patient global (0–10 cm) + evaluator global (0–10 cm) + CRP mg/dL. Newly proposed states: ≤3.3 remission, ≤11 low, ≤26 moderate, >26 high (not original 5/20/40). magent does not count joints or assay CRP. Not CDAI. Not a rheumatoid arthritis diagnosis.

Webster 1968 rating scale: ten caller-assigned integers 0-3 (bradykinesia, rigidity, posture, upper_extremity_swing, gait, tremor, facies, seborrhea, speech, self_care). magent sums only (max 30) and does not examine the patient. Score only; magent does not invent mild/moderate/severe total-score bands. Historical 10-item 0-30 sum. Not MDS-UPDRS and not a Parkinson diagnosis. Not a medical device.

Malcovati 2007 WPSS for MDS: WHO category (RA/RARS/5q- 0, RCMD/RCMD-RS 1, RAEB-1 2, RAEB-2 3), IPSS karyotype (good 0, intermediate 1, poor 2; caller assigns the three-group class), regular RBC transfusion 1 (at least one every 8 weeks over 4 months); max 6. very_low 0 through very_high 5–6. Not IPSS-R, not IPSS 1997, not DIPSS. magent does not karyotype or assign WHO category.

Jacobs 1990 risk of malignancy index: RMI = U × M × CA125 (U/ml). Caller assigns ultrasound_score 0, 1, or 3 (never 2) and postmenopausal (M=3 if true, else 1). Returns rmi to 1 decimal and exceeds_200 (true if RMI > 200). Not an ovarian-cancer diagnosis and not later RMI-2 or RMI-3.

Laughon 2011 simplified Bishop score from three caller-assigned Bishop 1964 integers: dilation, station, and effacement (each 0-3; max 9). Paper bins: dilation 0 / 1-2 / 3-4 / 5-6 cm; station -3 / -2 / -1 or 0 / +1 or +2; effacement 0-30 / 40-50 / 60-70 / 80%. favorable iff score >5 (Laughon compared with original Bishop >8; PPV 87.7% in that paper). magent does not examine the cervix or add consistency or position. Not a cervical exam or induction order.

Nadler 1962 adult blood volume plus exponential remaining-fraction washout (Y/Y0 = e^(−X)) for sickle RBC exchange replacement pRBC volume. FCR = target_hbs / initial_hbs; X = −ln(FCR). Caller supplies hematocrits and HbS percents. Optional approx units if unit_volume_ml is sent. Deterministic published arithmetic. Not an apheresis order or medical device.

Kaplan 1990 estimated plasma volume for therapeutic plasma exchange: epv_l = 0.065 * weight_kg * (1 - hematocrit_percent/100). Returns one plasma volume in liters and milliliters. Hematocrit is a percent (10-70), not a 0-1 fraction. Deterministic published arithmetic with citation. Not an apheresis order, Nadler blood volume, Ganzoni iron deficit, or a 1.5-PV / removal-percent table.

Continuous intravenous naloxone infusion as two-thirds of the caller-assigned reversal bolus each hour (Goldfrank 1986). infusion_mg_h = (2/3) * reversal_bolus_mg maintains plasma naloxone at or above the 30-minute post-bolus level. magent does not choose the bolus or start naloxone. Not a prescription or medical device.

ACOG Practice Bulletin 181 RhD immune globulin vial arithmetic. fmh_ml = fetal_cells_percent/100 * maternal_blood_volume_ml. One 300 microgram vial covers 30 mL Rh D-positive fetal whole blood. AABB Technical Manual rounding: if frac(fmh_ml/30) >= 0.5 round up then add one vial; if < 0.5 round down then add one. Minimum 1 vial. Caller assigns Kleihauer–Betke percent and maternal volume; magent does not read slides. Not a prescription or brand order.

Strander 2005 Swede score: five caller-assigned 0-2 items (acetowhiteness, margins_surface, vessels, lesion_size, iodine; Table I final rounded weights; max 10). swede_band <5, 5-7, or >=8 (≥5 identified all HGL in that derivation set; ≥8 had 90% specificity). magent does not read the colposcope. Not a CIN diagnosis, see-and-treat order, or Reid index.